Literature DB >> 1524803

Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas.

M E Christensen1, M H Therkildsen, B L Hansen, H Albeck, G N Hansen, P Bretlau.   

Abstract

The expression of the receptor for epidermal growth factor (EGF) has been determined on oral squamous cell carcinomas. Immunoreactive receptor was localized using a monoclonal anti-EGF-receptor antibody which reacts with sequences in the external domain of the receptor. Frozen sections were studied from 40 patients with squamous cell carcinomas. In 16 sections from the patients with the squamous cell carcinomas, normal differentiated oral mucosa was included and in 7 of these the patients had received preoperative radiotherapy. Sections from 6 other patients with squamous cell carcinoma contained dysplastic epithelia. EGF-receptor-positive cells were present in the basal cell layer on normal differentiated oral mucosa. In sections from patients receiving preoperative radiotherapy the EGF-receptor-positive cells were also found in the spinous cells. In dysplastic epithelia nearly all cells stained for the receptor. The distribution and staining intensity of the EGF receptor varied in the oral squamous cell carcinomas, 36 were positive. The staining pattern in the carcinomas obtained from patients receiving preoperative radiotherapy was not altered qualitatively. Nearly all poorly differentiated cells were stained, but when the tumor was moderately to well differentiated a reduction in the extent of staining in certain areas was seen, paralleling the findings observed in the differentiated upper layers of the normal oral mucosa. This was most pronounced for the epithelial pearls, where the EGF-receptor-positive cells were localized to the undifferentiated cells in the periphery. The results of the present investigation confirm the presence of the EGF receptor on undifferentiated cells, with the extent of the staining reaction on oral squamous cell carcinomas varying inversely with cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1524803     DOI: 10.1007/bf00714485

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  26 in total

1.  Expression of epidermal growth factor receptor in human gastric and colonic carcinomas.

Authors:  W Yasui; H Sumiyoshi; J Hata; T Kameda; A Ochiai; H Ito; E Tahara
Journal:  Cancer Res       Date:  1988-01-01       Impact factor: 12.701

Review 2.  Polypeptide growth factors.

Authors:  R James; R A Bradshaw
Journal:  Annu Rev Biochem       Date:  1984       Impact factor: 23.643

3.  Identification of epidermal growth factor receptors in a hyperproducing human epidermoid carcinoma cell line.

Authors:  M M Wrann; C F Fox
Journal:  J Biol Chem       Date:  1979-09-10       Impact factor: 5.157

Review 4.  The sequential analysis of cancer development.

Authors:  E Farber; R Cameron
Journal:  Adv Cancer Res       Date:  1980       Impact factor: 6.242

5.  Expression of epidermal growth factor receptor on oral squamous cell carcinoma.

Authors:  M Partridge; W J Gullick; J D Langdon; M Sherriff
Journal:  Br J Oral Maxillofac Surg       Date:  1988-10       Impact factor: 1.651

6.  Kirsten murine sarcoma virus transformed cell lines and a spontaneously transformed rat cell-line produce transforming factors.

Authors:  B Ozanne; R J Fulton; P L Kaplan
Journal:  J Cell Physiol       Date:  1980-10       Impact factor: 6.384

7.  High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer.

Authors:  S A Sherwin; D R Twardzik; W H Bohn; K D Cockley; G J Todaro
Journal:  Cancer Res       Date:  1983-01       Impact factor: 12.701

8.  Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.

Authors:  D E Neal; C Marsh; M K Bennett; P D Abel; R R Hall; J R Sainsbury; A L Harris
Journal:  Lancet       Date:  1985-02-16       Impact factor: 79.321

9.  High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines.

Authors:  T Yamamoto; N Kamata; H Kawano; S Shimizu; T Kuroki; K Toyoshima; K Rikimaru; N Nomura; R Ishizaki; I Pastan
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

10.  Increased EGF receptors on human squamous carcinoma cell lines.

Authors:  G P Cowley; J A Smith; B A Gusterson
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

View more
  15 in total

1.  [Immunotherapy of head and neck cancer. Identification of a novel mechanism for anti-EGFR mAb anti-tumor effects].

Authors:  T K Hoffmann
Journal:  HNO       Date:  2011-03       Impact factor: 1.284

2.  Immunolocalization of transforming growth factor alpha in normal human tissues.

Authors:  M E Christensen; S S Poulsen
Journal:  Histochem Cell Biol       Date:  1996-05       Impact factor: 4.304

Review 3.  [Squamous cell carcinoma of the head and neck. Principles and current concepts of immunotherapy].

Authors:  T K Hoffmann; T L Whiteside; H Bier
Journal:  HNO       Date:  2005-03       Impact factor: 1.284

4.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

5.  Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Authors:  L Licitra; R Mesia; F Rivera; É Remenár; R Hitt; J Erfán; S Rottey; A Kawecki; D Zabolotnyy; M Benasso; S Störkel; S Senger; C Stroh; J B Vermorken
Journal:  Ann Oncol       Date:  2010-11-03       Impact factor: 32.976

6.  Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro.

Authors:  J R Grandis; S D Drenning; A Chakraborty; M Y Zhou; Q Zeng; A S Pitt; D J Tweardy
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

Review 7.  Can immunohistochemistry serve as an alternative to subjective histopathological diagnosis of oral epithelial dysplasia?

Authors:  Ahmad A Abdulmajeed; Camile S Farah
Journal:  Biomark Cancer       Date:  2013-10-10

8.  Expression of epithelial growth factor receptor in oral epithelial dysplastic lesions.

Authors:  Manickam Rajakili Chockalingam Rajeswari; Thillai Rajasekaran Saraswathi
Journal:  J Oral Maxillofac Pathol       Date:  2012-05

9.  Phase II study of cetuximab plus concomitant boost radiotherapy in Japanese patients with locally advanced squamous cell carcinoma of the head and neck.

Authors:  Susumu Okano; Takayuki Yoshino; Masato Fujii; Yusuke Onozawa; Takeshi Kodaira; Hirofumi Fujii; Tetsuo Akimoto; Satoshi Ishikura; Masahiko Oguchi; Sadamoto Zenda; Barbara de Blas; Makoto Tahara; Frank Beier
Journal:  Jpn J Clin Oncol       Date:  2013-03-10       Impact factor: 3.019

10.  Platinum-based chemotherapy plus cetuximab for the first-line treatment of Japanese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: results of a phase II trial.

Authors:  Takayuki Yoshino; Yasuhisa Hasegawa; Shunji Takahashi; Nobuya Monden; Akihiro Homma; Kenji Okami; Yusuke Onozawa; Masato Fujii; Takahide Taguchi; Barbara de Blas; Frank Beier; Makoto Tahara
Journal:  Jpn J Clin Oncol       Date:  2013-03-10       Impact factor: 3.019

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.